In truth, it appears that TransMedics fueled its growth by engaging in an anti-competitive scheme, including providing kickbacks to medical providers. The company further boosted growth by engaging in ...
Needham analyst Michael Matson maintained a Hold rating on Boston Scientific (BSX – Research Report) today. The company’s shares closed ...
CENTRAL TRUST Co lifted its stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 162.2% in the 4th quarter, ...